{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:37Z","timestamp":1793411137006,"version":"4.5.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamaoncol.2018.4270","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:40:40Z","timestamp":1539715240000},"page":"181","source":"Crossref","is-referenced-by-count":130,"title":["Five-Year Risk of Cervical Precancer Following p16\/Ki-67 Dual-Stain Triage of HPV-Positive Women"],"prefix":"10.1001","volume":"5","author":[{"given":"Megan A.","family":"Clarke","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C.","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Tokugawa","sequence":"additional","affiliation":[{"name":"Kaiser Permanente TPMG Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[{"name":"Kaiser Permanente TPMG Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[{"name":"Kaiser Permanente TPMG Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[{"name":"Global Coalition Against Cervical Cancer, Arlington, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"coi180080r1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","article-title":"Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs.","volume":"143","author":"Cuschieri","year":"2018","journal-title":"Int J Cancer"},{"key":"coi180080r2","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening.","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"issue":"10","key":"coi180080r3","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/ijc.v140.10","article-title":"Eurogin 2016 roadmap: how HPV knowledge is changing screening practice.","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int J Cancer"},{"issue":"3","key":"coi180080r4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"coi180080r5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/cncy.21800","article-title":"Interobserver reproducibility of cytologic p16INK4a \/Ki-67 dual immunostaining in human papillomavirus-positive women.","volume":"125","author":"Benevolo","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"12","key":"coi180080r6","doi-asserted-by":"publisher","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women.","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"coi180080r7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening.","volume":"122","author":"Wentzensen","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"20","key":"coi180080r8","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study.","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"coi180080r9","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"coi180080r10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative: HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology.","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"coi180080r11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial.","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"5","key":"coi180080r12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0242-6498(06)70746-5","article-title":"The p16-INK4a protein: a cytological marker for detecting high grade intraepithelial neoplasia of the uterine cervix","volume":"26","author":"Bergeron","year":"2006","journal-title":"Ann Pathol"},{"issue":"2","key":"coi180080r13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"16","key":"coi180080r14","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"coi180080r15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ypmed.2017.12.004","article-title":"Challenges in risk estimation using routinely collected clinical data: the example of estimating cervical cancer risks from electronic health-records.","volume":"111","author":"Landy","year":"2018","journal-title":"Prev Med"},{"issue":"22","key":"coi180080r16","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.","volume":"36","author":"Cheung","year":"2017","journal-title":"Stat Med"},{"issue":"2","key":"coi180080r17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/M15-2735","article-title":"Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis.","volume":"166","author":"Arbyn","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"coi180080r18","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"1-2","key":"coi180080r19","first-page":"109","article-title":"A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides.","volume":"32","author":"Grabe","year":"2010","journal-title":"Cell Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/2\/181\/17295219\/jamaoncology_clarke_2018_oi_180080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:49:40Z","timestamp":1550162980000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.4270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.4270","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}